New hope for IBS sufferers

Copyright 2006 David McEvoy

A recent clinical trial has given further weight to the acceptance that supplemented dietary nucleotides, essential building blocks, can support the rapid production of new cells, which is beneficial for adult immunity and gut health.

This 2005 clinical trial, the effectiveness of a nucleotide supplement in the management of individuals with Irritable Bowel Syndrome (IBS), was sponsored by a grant from the Dept Trade and Industry, and conducted at the University of East London, under control of Professor Christine Dancey. Professor Dancey heads the Dept of Psychology and the Chronic Illness Research Team (CIRT) and is the co-founder of IBS Network.

IBS is one of the most prevalent chronic illnesses, and present